CY1117460T1 - Παραγωγο πυρρολιδιν-3-υλ οξικου οξεος - Google Patents
Παραγωγο πυρρολιδιν-3-υλ οξικου οξεοςInfo
- Publication number
- CY1117460T1 CY1117460T1 CY20161100224T CY161100224T CY1117460T1 CY 1117460 T1 CY1117460 T1 CY 1117460T1 CY 20161100224 T CY20161100224 T CY 20161100224T CY 161100224 T CY161100224 T CY 161100224T CY 1117460 T1 CY1117460 T1 CY 1117460T1
- Authority
- CY
- Cyprus
- Prior art keywords
- group
- groups
- substituted
- substituted groups
- unsubstituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Μία ένωση που υποδεικνύεται από τον τύπο (I) ή ένα φαρμακευτικά αποδεκτό άλας αυτού, που έχει ένα ανασταλτικό αποτέλεσμα σε μία οδό φρακταλκίνης-CΧ3CR1 [R αναπαριστά μία C1-6 αλκυλ ομάδα που έχει 1-3 μη υποκατεστημένες ομάδες ή 1-3 υποκατεστημένες ομάδες που επιλέγονται από μία ομάδα (Α) υποκατεστημένων ομάδων, μία C3-8 κυκλοαλκενυλ ομάδα που έχει 1-3 μη υποκατεστημένες ομάδες ή 1-3 υποκατεστημένες ομάδες που επιλέγονται από μία ομάδα (Α) υποκατεστημένων ομάδων, Χ υποδεικνύει μία C1-6, αλκυλ ομάδα,Υ και Ζ είναι τα ίδια ή διαφορετικά και υποδεικνύουν ένα άτομο αλογόνου ή μία C1-6 αλκυλ ομάδα που έχει 1-3 μη υποκατεστημένες ομάδες ή 1-3 υποκατεστημένες ομάδες που επιλέγονται από μία ομάδα (Β) υποκατεστημένων ομάδων, n αναπαριστά 0 ή 1, η ομάδα (Α) υποκατεστημένων ομάδων περιέχει άτομα αλογόνου. και η ομάδα (Β) υποκατεστημένων ομάδων περιέχει άτομα αλογόνου.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011199482 | 2011-09-13 | ||
EP12831085.1A EP2757103B1 (en) | 2011-09-13 | 2012-09-11 | Pyrrolidine-3-ylacetic acid derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1117460T1 true CY1117460T1 (el) | 2017-04-26 |
Family
ID=47883287
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20161100224T CY1117460T1 (el) | 2011-09-13 | 2016-03-16 | Παραγωγο πυρρολιδιν-3-υλ οξικου οξεος |
Country Status (32)
Country | Link |
---|---|
EP (1) | EP2757103B1 (el) |
JP (1) | JP5829689B2 (el) |
KR (1) | KR101963922B1 (el) |
CN (1) | CN103764648B (el) |
AR (1) | AR087788A1 (el) |
AU (1) | AU2012309556B2 (el) |
BR (1) | BR112014004267B1 (el) |
CA (1) | CA2844617C (el) |
CL (1) | CL2014000484A1 (el) |
CY (1) | CY1117460T1 (el) |
DK (1) | DK2757103T3 (el) |
ES (1) | ES2564732T3 (el) |
HK (1) | HK1193407A1 (el) |
HR (1) | HRP20160166T1 (el) |
HU (1) | HUE026824T2 (el) |
IL (1) | IL230804A (el) |
JO (1) | JO3082B1 (el) |
ME (1) | ME02383B (el) |
MX (1) | MX358494B (el) |
MY (1) | MY169869A (el) |
PE (1) | PE20141353A1 (el) |
PL (1) | PL2757103T3 (el) |
PT (1) | PT2757103E (el) |
RS (1) | RS54582B1 (el) |
RU (1) | RU2615135C2 (el) |
SG (1) | SG11201400163WA (el) |
SI (1) | SI2757103T1 (el) |
SM (1) | SMT201600071B (el) |
TW (1) | TWI543975B (el) |
UA (1) | UA112873C2 (el) |
WO (1) | WO2013039057A1 (el) |
ZA (1) | ZA201400918B (el) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5872105B2 (ja) | 2013-03-12 | 2016-03-01 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ピロリジン−3−イル酢酸誘導体の塩およびその結晶 |
WO2014142086A1 (ja) * | 2013-03-13 | 2014-09-18 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ピロリジン-3-イル酢酸誘導体およびピペリジン-3-イル酢酸誘導体 |
US20240199558A1 (en) | 2022-10-19 | 2024-06-20 | Astrazeneca Ab | 2,4,6-trisubstituted 1,3,5-triazines as modulators of cx3cr1 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4263391B2 (ja) | 2001-03-19 | 2009-05-13 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 抗cx3cr1抗体、抗フラクタルカイン抗体及びフラクタルカインの利用 |
WO2003037271A2 (en) * | 2001-10-30 | 2003-05-08 | Millennium Pharmaceuticals,Inc. | Compounds, pharmaceutical compositions and methods of use therefor |
BRPI0415050A (pt) * | 2003-10-07 | 2006-11-28 | Astrazeneca Ab | composto, formulação farmacêutica, método para tratar ou reduzir risco de uma doença ou condição humanas, uso de um composto ou de um sal deste farmaceuticamente aceitável, e, processo para a preparação de um composto ou de um sal deste farmaceuticamente aceitável |
UA90707C2 (en) | 2005-04-06 | 2010-05-25 | Астразенека Аб | Novel 5-substituted 7-amino-[1,3]thiazolo[4,5-d]pyrimidine derivatives |
AR053347A1 (es) * | 2005-04-06 | 2007-05-02 | Astrazeneca Ab | Derivados de [1,3]tiazolo[4,5-d]pirimidin-2(3h)-ona 5,7-sustituidos |
TW200820973A (en) | 2006-09-29 | 2008-05-16 | Astrazeneca Ab | Novel compounds 480 |
WO2008039139A1 (en) | 2006-09-29 | 2008-04-03 | Astrazeneca Ab | Novel 5,7-disubstituted [1, 3] thiazolo [4, 5] pyrimidin-2 (3h)-amine derivatives and their use in therapy |
TW200831497A (en) * | 2006-10-12 | 2008-08-01 | Epix Delaware Inc | Carboxamide compounds and their use |
MX2010009624A (es) * | 2008-03-07 | 2010-09-28 | Acraf | Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1 y cx3cr1. |
AR071036A1 (es) | 2008-03-26 | 2010-05-19 | Astrazeneca Ab | Derivados 5, 7-disustituidos de [1, 3]tiazolo[4, 5-d]pirimidin-2 (3h)-ona, una composicion farmaceutica que los comprende y su uso en el tratamiento de enfermedades mediadas por el receptor cx3cr1. |
-
2012
- 2012-09-05 JO JOP/2012/0251A patent/JO3082B1/ar active
- 2012-09-05 TW TW101132401A patent/TWI543975B/zh not_active IP Right Cessation
- 2012-09-06 AR ARP120103280A patent/AR087788A1/es active IP Right Grant
- 2012-09-11 MY MYPI2014700213A patent/MY169869A/en unknown
- 2012-09-11 AU AU2012309556A patent/AU2012309556B2/en not_active Ceased
- 2012-09-11 WO PCT/JP2012/073171 patent/WO2013039057A1/ja active Application Filing
- 2012-09-11 EP EP12831085.1A patent/EP2757103B1/en active Active
- 2012-09-11 KR KR1020147003630A patent/KR101963922B1/ko active IP Right Grant
- 2012-09-11 BR BR112014004267-5A patent/BR112014004267B1/pt not_active IP Right Cessation
- 2012-09-11 DK DK12831085.1T patent/DK2757103T3/en active
- 2012-09-11 RS RS20160106A patent/RS54582B1/en unknown
- 2012-09-11 PL PL12831085T patent/PL2757103T3/pl unknown
- 2012-09-11 JP JP2013533669A patent/JP5829689B2/ja not_active Expired - Fee Related
- 2012-09-11 ES ES12831085.1T patent/ES2564732T3/es active Active
- 2012-09-11 PT PT128310851T patent/PT2757103E/pt unknown
- 2012-09-11 SI SI201230463T patent/SI2757103T1/sl unknown
- 2012-09-11 CA CA2844617A patent/CA2844617C/en active Active
- 2012-09-11 MX MX2014002210A patent/MX358494B/es active IP Right Grant
- 2012-09-11 SG SG11201400163WA patent/SG11201400163WA/en unknown
- 2012-09-11 CN CN201280041634.0A patent/CN103764648B/zh not_active Expired - Fee Related
- 2012-09-11 RU RU2014107536A patent/RU2615135C2/ru active
- 2012-09-11 HU HUE12831085A patent/HUE026824T2/en unknown
- 2012-09-11 PE PE2014000266A patent/PE20141353A1/es active IP Right Grant
- 2012-09-11 ME MEP-2016-37A patent/ME02383B/me unknown
- 2012-11-09 UA UAA201401661A patent/UA112873C2/uk unknown
-
2014
- 2014-02-03 IL IL230804A patent/IL230804A/en active IP Right Grant
- 2014-02-06 ZA ZA2014/00918A patent/ZA201400918B/en unknown
- 2014-02-27 CL CL2014000484A patent/CL2014000484A1/es unknown
- 2014-07-04 HK HK14106800.1A patent/HK1193407A1/xx not_active IP Right Cessation
-
2016
- 2016-02-16 HR HRP20160166TT patent/HRP20160166T1/hr unknown
- 2016-03-10 SM SM201600071T patent/SMT201600071B/xx unknown
- 2016-03-16 CY CY20161100224T patent/CY1117460T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1121549T1 (el) | Ενωσεις 1-αρυλκαρβονυλ-4-oξυ-πιπεριδινης χρησιμες για την αγωγη νευροεκφυλιστικων παθησεων | |
CY1119422T1 (el) | Παραγωγα μπετουλινης | |
CY1120480T1 (el) | Ενωσεις πυραζολοπυριμιδινης | |
CY1122821T1 (el) | Παραγωγα 1,3-βενζοδιοξολιου ως αναστολεις εζη1 ή/και εζη2 | |
CY1121792T1 (el) | Ετεροκυκλικη ενωση | |
CY1124537T1 (el) | Παραγωγο πυριδονης που εχει τετραϋδροπυρανυλ μεθυλ ομαδα | |
CY1119620T1 (el) | Αναστολεις νεπριλυσινης | |
CY1121804T1 (el) | Καινοτομες ενωσεις πυριμιδινης και πυριδινης και η χρηση τους | |
CY1119134T1 (el) | Υποδοχεις της νεπριλυσινης | |
PH12014501719B1 (en) | Pyridone derivatives | |
EA201591497A1 (ru) | Новые производные октагидропирроло[3,4-c]пиррола и их аналоги в качестве ингибиторов аутотаксина | |
CY1119220T1 (el) | Μονοκυκλικο παραγωγο πυριδινης | |
IN2014MN02574A (el) | ||
CY1117923T1 (el) | Αζωτουχος ετεροκυκλικη ενωση και γεωργικο ή κηπουρικο μυκητοκτονο | |
CY1121626T1 (el) | Νεο παραγωγο υδροξαμικου οξεος ή αλας αυτου | |
AU2013348091A8 (en) | Synthesis of spirocyclic isoxazoline derivatives | |
MY161134A (en) | Piperazine compound having a pgds inhibitory effect | |
CY1117026T1 (el) | Ετεροκυκλικες ενωσεις για αντιμετωπιση ή προληψη διαταραχων που προκαλουνται απο μειωμενη νευροδιαβιβαση σεροτονινης, νορεπινεφρινης ή ντοπαμινης | |
MX2013007938A (es) | Compuesto biciclico novedoso o sal del mismo. | |
CY1122439T1 (el) | Κυκλοαλκυλ-συνδεδεμενα παραγωγα δι-ετεροκυκλων | |
CL2020000376A1 (es) | Compuesto pentacíclico. | |
MX2016002718A (es) | Derivados de ceto-imidazopiridina como moduladores del receptor huerfano relacionado con receptor retinoide (porc). | |
CY1122477T1 (el) | Παραγωγα πυριδο-οξαζινονης ως αναστολεις tnap | |
CY1117460T1 (el) | Παραγωγο πυρρολιδιν-3-υλ οξικου οξεος | |
CY1119316T1 (el) | Υδροχλωρικα αλατα μιας αντιβιοτικης ενωσης |